FNY Managed Accounts’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-180
Closed -$1K 324
2017
Q1
$1K Buy
+180
New +$1.14K ﹤0.01% 723
2016
Q4
Sell
-5,000
Closed -$37K 118
2016
Q3
$37K Buy
+5,000
New +$33.8K 0.03% 230

Other funds holding FOLD

FNY Managed Accounts's FOLD Position: Q2 2017 in Review

FNY Managed Accounts sold out of Amicus Therapeutics (FOLD) in Q2 2017, closing a stake of 180 shares — an estimated $1K sold.

FNY Managed Accounts first reported a position in FOLD in Q3 2016 and held it in 2 quarters. The position peaked at $37K in Q3 2016. 141 funds tracked by Wall St. Rank hold FOLD as of Q2 2017.

  • FNY Managed Accounts reported no remaining Amicus Therapeutics position as of Q2 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 180 Amicus Therapeutics shares in Q2 2017, an estimated $1K.
  • FNY Managed Accounts first reported a position in Amicus Therapeutics in Q3 2016 and held it in 2 quarters.
  • FNY Managed Accounts's Amicus Therapeutics position peaked at $37K in Q3 2016.
  • 141 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.